| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.04. | Kiniksa Pharmaceuticals, Ltd.: Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart | 74 | GlobeNewswire (Europe) | - Abiprubart Phase 2b trial in Sjogren's Disease planned to initiate in 2H 2024 -- Abiprubart Phase 2 Cohort 4 rheumatoid arthritis data further validate biological activity -- Abiprubart development... ► Artikel lesen | |
| 02.04. | Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Company | 151 | GlobeNewswire (Europe) | Closing cash balance of approximately $28 million expected from concurrent private placement led by OrbiMed and Torrey PinesFunding expected to advance development of three potential best-in-class/class... ► Artikel lesen | |
| 02.04. | FibroGen, Inc.: FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer | 170 | GlobeNewswire (Europe) | FG-3246 demonstrated efficacy in adenocarcinoma selected cohorts receiving biologically active doses of FG-3246 at = 1.2 mg/kg in heavily pre-treated, biomarker unselected patients: Median radiographic... ► Artikel lesen | |
| 02.04. | Sow Good Inc.: Sow Good Appoints Brendon Fischer as Interim Chief Financial Officer | 78 | GlobeNewswire (Europe) | IRVING, Texas, April 02, 2024 (GLOBE NEWSWIRE) -- Sow Good Inc. (OTCQB: SOWG) ("Sow Good" or "the Company"), a trailblazer in the freeze dried candy and treat industry, announced today that Brendon... ► Artikel lesen | |
| 02.04. | Fluent, Inc.: Fluent Announces Fourth Quarter and Full-Year 2023 Financial Results | 198 | GlobeNewswire (Europe) | Revenue of $72.8 million for Q4 2023 and $298.4 million for FY 2023Net loss of $1.9 million for Q4 2023 and $63.2 million for FY 2023Gross profit (exclusive of depreciation and amortization) of $20.8... ► Artikel lesen | |
| 02.04. | Intermap Technologies: Intermap Announces 2023 Results and 2024 Guidance | 119 | GlobeNewswire (Europe) | Software and solutions revenue grew 25% in 2023 Company projects 2024 bookings of $20 - 25 million, revenue of $16 - 18 million and an adjusted EBITDA margin of approximately 25% DENVER, April 02... ► Artikel lesen | |
| 02.04. | Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 176 | GlobeNewswire (Europe) | BOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies... ► Artikel lesen | |
| 02.04. | D-BOX Technologies Inc.: Joshua Chandler joins D-BOX as the new Chief Financial Officer | 121 | GlobeNewswire (Europe) | MONTREAL, April 02, 2024 (GLOBE NEWSWIRE) -- D-BOX Technologies Inc. ("D-BOX" or the "Corporation") (TSX:DBO), a world leader in haptic and immersive entertainment, is pleased to announce the appointment... ► Artikel lesen | |
| 02.04. | African Rainbow Minerals Limited Acquires Shares of Surge Copper Corp. | 302 | GlobeNewswire (Europe) | TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- African Rainbow Minerals Limited (JSE: ARI) (A2X: ARI) ("ARM") announces that it has agreed to subscribe for, through its wholly-owned subsidiary ARM Copper... ► Artikel lesen | |
| 02.04. | Centogene NV: CENTOGENE Receives Nasdaq Non-Compliance Notice | 333 | GlobeNewswire (Europe) | CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, April 02, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) ("Centogene", "we", or the "Company"), the essential life science partner for data-driven... ► Artikel lesen | |
| 02.04. | Edible Garden AG Incorporated: Edible Garden Announces Reverse Stock Split of the Company's Common Stock | 125 | GlobeNewswire (Europe) | BELVIDERE, NJ, April 02, 2024 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally... ► Artikel lesen | |
| 02.04. | Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 145 | GlobeNewswire (Europe) | SAN FRANCISCO, April 02, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. ("Olema" or "Olema Oncology", Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development... ► Artikel lesen | |
| 02.04. | Microchip Technology Inc.: Microchip Technology Appoints Rich Simoncic as Chief Operating Officer | 205 | GlobeNewswire (Europe) | CHANDLER, Ariz., April 02, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: MCHP) - Microchip Technology Incorporated, a leading provider of smart, connected and secure embedded control solutions, today announced... ► Artikel lesen | |
| 02.04. | Nanobiotix S.A.: Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation | 121 | GlobeNewswire (Europe) | Established recommended Phase 2 dose of NBTXR3 for the treatment of patients with inoperable, recurrent non-small cell lung cancer ("NSCLC") who have previously received definitive radiation therapyConfirmation... ► Artikel lesen | |
| 02.04. | Locafy Limited: Locafy Reports Fiscal First Half 2024 Results | 226 | GlobeNewswire (Europe) | Fiscal First Half 2024 Highlighted by Ongoing Cost Reduction Initiatives Resulting in $3.6 Million Year-Over-Year Decrease in Operating Expenses Partnerships with diDNA and Localista, Hotfrog Proximity... ► Artikel lesen | |
| 02.04. | View, Inc. Reaches Agreement with Cantor Fitzgerald and RXR to Become a Private Company | 207 | GlobeNewswire (Europe) | Balance sheet restructuring designed to strengthen View's financial position Approvals received from key stakeholders across capital structure MILPITAS, Calif., April 02, 2024 (GLOBE NEWSWIRE) --... ► Artikel lesen | |
| 02.04. | X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 119 | GlobeNewswire (Europe) | BOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective... ► Artikel lesen | |
| 02.04. | Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue | 182 | GlobeNewswire (Europe) | SEATTLE, April 02, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune... ► Artikel lesen | |
| 02.04. | Marathon Digital Holdings Inc.: Marathon Digital Holdings Announces the Closing of its Acquisition of a 200-Megawatt Bitcoin Mining Data Center Adjacent to a Wind Farm | 235 | GlobeNewswire (Europe) | Fort Lauderdale, FL, April 02, 2024 (GLOBE NEWSWIRE) -- Marathon Digital Holdings, Inc. (NASDAQ:MARA) ("Marathon" or "Company"), one of the world's largest publicly traded Bitcoin miners and a leader... ► Artikel lesen | |
| 02.04. | Pulmonx Corporation: Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer | 146 | GlobeNewswire (Europe) | REDWOOD CITY, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced... ► Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 1.682 |
| NEL | 1.667 |
| SUPER MICRO COMPUTER | 1.656 |
| NVIDIA | 1.650 |
| TUI | 1.484 |
| BAYER | 1.336 |
| RHEINMETALL | 1.000 |
| RENK GROUP | 930 |
| PROSIEBENSAT.1 | 912 |
| VOLKSWAGEN | 735 |
| AMAZON | 699 |
| PALANTIR TECHNOLOGIES | 698 |
| TESLA | 687 |
| MICROSTRATEGY | 636 |
| DEUTSCHE BANK | 585 |
| PLUG POWER | 571 |
| BASF | 565 |
| BYD | 557 |
| THYSSENKRUPP | 542 |
| COMMERZBANK | 535 |
| AIXTRON SE | 532 |
| SAP | 507 |
| MERCEDES-BENZ | 506 |
| ALLIANZ | 493 |
| DEUTSCHE TELEKOM | 473 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
